All articles tagged with #blood oxygen feature
Originally Published 4 months ago — by MacRumors
The beta versions of iOS 26 and watchOS 26 include a redesigned Blood Oxygen feature available in the U.S., enhancing health monitoring capabilities.
Originally Published 4 months ago — by Forbes
Apple has released iOS 18.6.1, primarily to restore the blood oxygen monitoring feature on certain Apple Watch models affected by a patent dispute, with some users reporting improved performance on their iPhones. The update is recommended for all compatible devices, especially those with Apple Watches, and includes no new security features. A final assessment will be provided after further testing.
Originally Published 1 year ago — by The Verge
If you own a pre-ban Apple Watch with the blood oxygen feature, be cautious about replacing it through AppleCare, as there is uncertainty about whether the feature will be retained in the replacement. Apple has informed AppleCare representatives that replacements may not include this feature, creating uncertainty for users who may need to replace their watches.
Originally Published 2 years ago — by Daily Mail
The now-axed blood oxygen feature of the Apple Watch has been credited with saving a woman's life after she collapsed on a flight. A doctor used the feature to monitor the woman's vitals and determine her low oxygen saturation, allowing him to stabilize her until the plane landed. The feature has been disabled in new Apple Watch models due to a patent infringement lawsuit, but still operates in previously purchased units. Apple's legal battle with medical technology company Masimo led to the removal of the feature, despite claims that it can save lives.
Originally Published 2 years ago — by 9to5Mac
Masimo CEO Joe Kiani criticized Apple for offering an unreliable blood oxygen feature on the Apple Watch, leading to a patent dispute and a US court ruling that forced Apple to stop selling certain models. Apple has disabled the blood oxygen feature on the affected models to comply with the ban, while asserting that the feature is reliable and can save lives. Studies have shown that the Apple Watch's blood oxygen monitoring results are fairly accurate and similar to those of other devices, but the dispute between Masimo and Apple is expected to continue.
Originally Published 2 years ago — by AnandTech
Apple is set to remove the blood oxygen measurement feature from its newly-sold Watch Series 9 and Watch Ultra 2 in the U.S. following a legal defeat in a patent infringement fight with Masimo. The U.S. Court of Appeals' decision means that Apple must stop selling watches with this feature while the appeal is in progress, leading the company to disable the feature in software for the immediate future. Despite the change, Apple continues to appeal the USITC's decision, and the blood oxygen feature will still be available in models sold outside the U.S.
Originally Published 2 years ago — by CNBC
Apple will continue selling its latest Apple Watches in the U.S. by removing the blood oxygen feature, following an intellectual property dispute with Masimo. The modified versions of the Apple Watch Series 9 and Ultra 2 will be available without the feature, as the company battles a court decision that found the watch sensors infringed on Masimo's patents. Apple hopes the appeals court will eventually reverse the decision, but in the meantime, it aims to comply with the ruling while minimizing disruption to customers.
Originally Published 2 years ago — by The Verge
Apple will start selling the Apple Watch Series 9 and Apple Watch Ultra 2 without their blood oxygen features in response to a US ban, with the revised watches available on Apple's website and retail stores. The company has developed a software workaround and is appealing the decision, assuring that existing devices with the blood oxygen feature will not be impacted.
Originally Published 2 years ago — by Bloomberg
Apple has been dealt a legal blow in its patent dispute with Masimo Corp, as the US Court of Appeals for the Federal Circuit has declined to grant the company a longer pause on an import ban of its Series 9 and Ultra 2 smartwatches with a blood oxygen feature. This means Apple must stop selling the watches with the oxygen measurement feature while an appeal of the ban plays out, which the company believes could last a year or more.
Originally Published 2 years ago — by Gizmodo
Apple has found a way to work around the import ban on its Apple Watch Series 9 and Ultra 2 by removing the blood oxygen measurement feature, following a legal battle with health-tech company Masimo. The ban, which took the watches off Apple's shelves, led to the proposed solution being accepted by Masimo, and the new watches without the oximeter feature have been shipped to retailers in the US, pending approval from Apple's corporate office before they can be sold.
Originally Published 2 years ago — by Business Insider
Apple may remove the blood oxygen feature from its Apple Watch Series 9 and Ultra 2 if its appeal of the import ban is unsuccessful, following a claim by medical device maker Masimo that certain Apple Watch models infringe on its blood oxygen monitoring technology patents. Masimo stated that US Customs and Border Protection found Apple's redesign to be outside the scope of the import ban, and Apple told them that the redesigned watches do not contain pulse oximetry functionality. The import ban initially took effect on December 26, but the US Court of Appeals for the Federal Circuit temporarily paused it, allowing Apple to continue sales while it fights the ban.
Originally Published 2 years ago — by The Verge
The blood oxygen feature is being removed from the new Apple Watch Series 9 and Watch Ultra 2 devices in an effort to avoid a ban resulting from a patent dispute with medical device maker Masimo. US Customs and Border Protection has approved this measure, allowing Apple to consider selling the products again. The feature appears to still be active on watches already sold, but it's unclear how long this will be the case. Apple spokesperson Nikki Rothberg stated that the watches would continue to be available with the feature, but it's advised to carefully check for updates and consider holding off on purchasing a new Apple Watch if the blood oxygen feature is important to you.
Originally Published 2 years ago — by Reuters
Apple will temporarily halt sales of its Series 9 and Ultra 2 smartwatches in the United States due to a patent dispute with medical technology company Masimo. The U.S. International Trade Commission (ITC) had previously ordered a potential ban on Apple Watch imports, citing patent violations. The decision is currently under review by President Joe Biden until December 25. If the ruling stands, the ban would go into effect on December 26. Apple intends to appeal the decision and is working on technical options to ensure the availability of its watches. The sales pause will not affect other Apple Watch models or sales outside of the United States.